Epinephrine enhances penetration and anti-cancer activity of local cisplatin on rat sub-cutaneous and peritoneal tumors

International Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 779-784

  Duvillard, Christian ^a   Benoit, Laurent ^a   Moretto, Philippe ^b   Beltramo, Jean Luc ^c   Brunet Lecomte, Patrick ^d   Correia, Maria ^a   Sergent, Catherine ^a   Chauffert, Bruno ^a  

^a INSERM   (France)

^b CENTRE D ETUDES NUCLÉAIRES DE BORDEAUX GRADIGNAN   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CISPLATIN; DISULFINE BLUE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMATOUS PERITONITIS; COLON TUMOR; CONTROLLED STUDY; DRUG PENETRATION; DRUG POTENTIATION; FEMALE; GLIOMA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PERITONEUM TUMOR; PRIORITY JOURNAL; RAT; SUBCUTANEOUS TISSUE TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; COLORING AGENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EPINEPHRINE; FEMALE; INJECTIONS; PERITONEAL NEOPLASMS; RATS; RATS, INBRED STRAINS; ROSANILINE DYES; SKIN NEOPLASMS; SPECTROMETRY, X-RAY EMISSION; SURVIVAL RATE; TUMOR CELLS, CULTURED; VASOCONSTRICTOR AGENTS;

EID: 0032962941     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990531)81:5<779::AID-IJC19>3.0.CO;2-I     Document Type: Article

References (29)

1. BOUCHER, Y. and JAIN, R.K., Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res., 52, 5110-5114 (1992).
2. BOUVIER, G., PENN, R.D., KROIN, J.S., BEIQUF, R.A., GERARD, M. and LESAGE, J., Intratumoral chemotherapy with multiple sources. Ann. N.Y. Acad. Sci., 531, 213-214 (1988).
3. BRENNER, D.E., Intraperitoneal chemotherapy: a review. J. clin. Oncol., 4, 1135-1147 (1986).
4. BURRIS, H.A., VOGEL, C.L., CASTRO, D., MISHRA, L., SCHWARZ, M., SPENCER, S., OAKES, D.D., KOREY, A. and ORENBERG, E.K., Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol. Head Neck Surg., 118, 496-503 (1998).
5. CHAUFFERT, B., DIMANCHE-BOITREL, M.T., GENNE, P., PETIT, J.M., ONIER, N. and JEANNIN, J.F., Chimiothérapic expérimentale d'une carcinomatose péritonéale d'origine colique chez le rat. Gastroenterol. clin. Biol., 16, 215-219 (1992).
6. COLLINS, J.M., DEDRICK, R.L., FLESSNER, M.F. and GUARNIO, A.M., Concentration-dependent disappearance of fluorouracil from peritoneal fluid in the rat: experimental observations and distributed modeling. J. pharm. Sci., 71, 735-738 (1982).
7. CORNAIN, S., CARNAUD, C., SILVERMAN, D., KLEIN, E. and RAJEWSKY, M.F., Spleen-cell reactivity against transplanted neurogenic rat tumors induced by ethylnitrosourea: uncovering of tumor specificity after removal of complement-receptor-bearing lymphocytes. Int. J. Cancer, 16, 301-311 (1975).
8. COUNCIL OF EUROPE: EUROPEAN TREATIES. ETS 123. European convention for the protection of vertebrate animals used for experimental and other scientific purposes. Strasbourg (1986).
9. DEDRICK, R.L., Theoretical and experimental bases of intra-peritoneal chemotherapy. Semin. Oncol., 12(Suppl 4), 1-6 (1985).
10. EASTMAN, A., Activation of programmed cell death: Cisplatin as a model system. Cancer Cells, 2, 275-280 (1990).
11. HARPER, S.L., BOHLEN, H.G. and GRANGER, D.N., Vasoactive agents and the mesenteric circulation. Amer. J. Physiol., 249, G309-G315 (1985).
12. HIRZEL, P., LARISCH, M. and MAHER, J.F., Divergent effects of catecholamines on peritoneal mass transport. Trans. Amer. Soc. artif. intern. Organs, 25, 110-113 (1979).
13. HOWELL, S.B., ZIMM, S. and MATKMAN, M., Long-term survival of advanced refractory-ovarian-carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. J. clin. Oncol., 5, 1607-1612 (1987).
14. JACQUET, B., VIDAL JOVE, J., ZHU, B. and SUGARBAKER, P.H., Peritoneal carcinomatosis from gastrointestinal malignancies: natural history and new prospects for management. Arch. Chir. Belg., 94, 191-197 (1994).
15. JACQUET, P. and SUGARBAKER, P.H., Peritoneal-plasma barrier. Cancer Treat. Res., 82, 53-63 (1996).
16. JAIN, R.K., Barriers to drug delivery in solid tumors. Sci. Amer., 271, 58-65 (1994).
17. KURTIS, B. and ROSEN, T., Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU). J. dermatol. Surg. Oncol., 6, 122-127 (1980).
18. LANDRITO, J.L., YOSHIGA, K., SAKURAI, K. and TAKADA, K., Effects of intralesional injection of cisplatin on squamous-cell carcinoma and normal tissue of mice. Anticancer Res., 14, 113-118 (1994).
19. LIVRAGHI, T., BAJETTA, E., MATRICARDI, I., VILLA, E., LOVATTI, R. and VETTOERI, C., Fine-needle percutaneous intratumoral chemotherapy under ultrasound guidance: a feasibility study. Tumori, 72, 81-87 (1986).
20. LOS, G. and MCVIE, J.G., Experimental and clinical status of intraperitoneal chemotherapy. Europ. J. Cancer, 26, 755-762 (1990).
21. LOS, G., MUTSAERS, P.H.A., VAN DER VIGH, W.J.G., BALDEW, G.S., DE GRAAF, P.W. and MCVIE, J.G., Direct diffusion of cis-diamminedichloroplatinum (II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: comparison with systemic chemotherapy. Cancer Res., 49, 3380-3384 (1989).
22. MARKMAN, M., REICHMAN, B. and HAKES, T., Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small volume residual ovarian cancer. J. clin. Oncol., 10, 1479-1484 (1992).
23. MARTIN, F., CAIGNARD, A., JEANNIN, J.F., LECLERC, A. and MARTIN, M.S., Selection by trypsin of two sublines of rat colon cancer cells forming regressive or progressive tumours. Int. J. Cancer, 32, 623-627 (1983).
24. MORETTO, P., Nuclear microprobe: a microanalytical technique in biology. Cell. mol. Biol., 42, 1-16 (1996).
25. MORIAI, T., MAKINO, T.T. and ISHII, K., Intratumoral treatment of pancreatic cancer with mitomycin-C adsorbed to carbon particles. A clinical trial on 15 cases. Anticancer Res., 9, 1799-1804 (1989).
26. MYERS, C.E. and COLLINS, J.M., Pharmacology of intraperitoneal chemotherapy. Cancer Invest., 1, 395-407 (1983).
27. OZOLS, R.F., Ovarian cancer. Curr. Probl. Cancer, 11, 57-122 (1987).
28. WALTER, K.A., TAMARGO, R.J., OLIVI, A., BURGER, P.C. and BREM, H., Intratumoral chemotherapy. Neurosurgery, 37, 1129-1145 (1995).
29. WENZEL, M., SCHNEIDER, M., BIER, J., BENDERS, P. and SCHACHSCHNEIDER, G., Cytostatika-Konzentrationen in Organen und Tumoren: Vergleich nach intravenöser und intratumoraler injektion. J. Cancer Res. clin. Oncol., 95, 147-157 (1979).